STOCK TITAN

Integer Holdings Corporation (ITGR) 10-K Filings

ITGR NYSE

Here are the 10-K annual reports from Integer Holdings Corporation (ITGR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow ITGR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ITGR filings page.

Rhea-AI Summary

Integer Holdings Corporation is a Plano, Texas–based medical device contract developer and manufacturer focused on Cardio & Vascular, Cardiac Rhythm Management and Neuromodulation markets. It operates as a pure-play medtech CDMO, supplying components, subassemblies and finished devices to large OEM customers worldwide.

In 2025, Integer completed three tuck-in acquisitions—Biocoat, VSi Parylene and Precision Coating—to deepen high-value coating and processing capabilities. Three major customers, Abbott Laboratories, Boston Scientific and Medtronic, each exceeded 10% of sales and together represented 49% of 2025 revenue. Backlog was approximately $675 million at December 31, 2025.

The company plans to exit its Portable Medical business by 2026 and emphasizes operational excellence through its Integer Operating and Production Systems. It highlights extensive global manufacturing, heavy regulation, cybersecurity exposure, raw-material and supply-chain risks, customer concentration, competitive pressure and evolving ESG and climate-related requirements as key risk factors.